Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed

被引:20
作者
Ralevic, V [1 ]
机构
[1] Univ Nottingham, Sch Med, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England
关键词
capsaicin-sensitive sensory nerves; endothelium; N-G-nitro-L-arginine methyl ester; 7-nitroindazole; neuromodulation; nitric oxide; rat mesenteric arterial bed;
D O I
10.1038/sj.bjp.0704837
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 A possible role of nitric oxide (NO) as a modulator of capsaicin-sensitive sensory neurotransmission in blood vessels was investigated in the rat isolated mesenteric arterial bed. 2 Electrical field stimulation (EFS) of methoxamine-preconstricted mesenteric beds elicited frequency-dependent vasorelaxation mediated by capsaicin-sensitive sensory nerves. N-G-nitro-(L)-arginine methyl ester ( (L)-NAME, 10 and 300 mum) and 7-nitroindazole (7-NI, 100 muM), inhibitors of nitric oxide synthase (NOS), augmented sensory neurogenic vasorelaxation. (D)-NAME (300 mum), 6-aminoindazole (100 mum) and N-psi-propyl-(L)-arginine (50 nM), a selective inhibitor of neuronal NOS, were without effect. The effect of 10 muM (L)-NAME was reversed by (L)-arginine (I mm), the substrate for NOS. 3 (L)-NAME (300 pm) and 7-NI (100 muM) had no significant effect on vasorelaxations to calcitonin gene-related peptide (CGRP), the principal motor neurotransmitter of capsaicin-sensitive sensory nerves in rat mesenteric arteries, or to capsaicin, indicating a prejunctional action. The inhibitors of NOS had no effect on vasorelaxation to forskolin, but augmented vasorelaxation to sodium nitroprusside (SNP). 4 Removal of the endothelium augmented sensory neurogenic vasorelaxation, but did not affect vasorelaxation to CGRP, indicating a prejunctional action of endothelial NO. 5 In the absence of endothelium, (L)-NAME (300 muM) inhibited, and 7-NI (100 muM) caused no further augmentation of sensory neurotransmission. 6 SNP (100 muM), a nitric oxide donor, attenuated sensory neurogenic relaxations to EFS. 7 In rat isolated thoracic aortic rings, (L)-NAME (100 muM) and 7-NI (100 muM) attenuated concentration-dependent relaxations to acetylcholine. 8 These data show that NO modulates sensory neuro transmission evoked by EFS of the rat isolated mesenteric arterial bed, and that when NO synthesis is blocked sensory neurogenic relaxation is augmented. The source of NO is the vascular endothelium.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 58 条
[1]   VARYING EXTRACELLULAR [K+] - A FUNCTIONAL-APPROACH TO SEPARATING EDHF-RELATED AND EDNO-RELATED MECHANISMS IN PERFUSED RAT MESENTERIC ARTERIAL BED [J].
ADEAGBO, ASO ;
TRIGGLE, CR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (03) :423-429
[2]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[3]   NITRIC-OXIDE IS NOT INVOLVED IN THE EFFECTS INDUCED BY NONADRENERGIC NONCHOLINERGIC STIMULATION AND CALCITONIN-GENE-RELATED PEPTIDE IN THE RAT MESENTERIC VASCULAR BED [J].
AMERINI, S ;
MANTELLI, L ;
LEDDA, F .
NEUROPEPTIDES, 1993, 25 (01) :51-56
[4]   Relatively selective neuronal nitric oxide synthase inhibition by 7-nitroindazole in monkey isolated cerebral arteries [J].
Ayajiki, K ;
Fujioka, H ;
Okamura, T ;
Toda, N .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 423 (2-3) :179-183
[5]  
BARJA F, 1983, CELL TISSUE RES, V229, P411
[6]  
BLANDWARD PA, 1995, LIFE SCI, V57, P131
[7]   Sensitization of rat sensory neurons by chronic exposure to forskolin or 'inflammatory cocktail' does not downregulate and requires continuous exposure [J].
Bolyard, LA ;
Van Looy, JW ;
Vasko, MR .
PAIN, 2000, 88 (03) :277-285
[8]   EVIDENCE FOR THE INVOLVEMENT OF BOTH ATP AND NITRIC-OXIDE IN NONADRENERGIC, NONCHOLINERGIC INHIBITORY NEUROTRANSMISSION IN THE RABBIT PORTAL-VEIN [J].
BRIZZOLARA, AL ;
CROWE, R ;
BURNSTOCK, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (03) :606-608
[9]   Sensitization of visceral afferents to bradykinin in rat jejunum in vitro [J].
Brunsden, AM ;
Grundy, D .
JOURNAL OF PHYSIOLOGY-LONDON, 1999, 521 (02) :517-527
[10]  
BUSSE R, 1989, J CARDIOVASC PHARM, V14, pS81